349-66-6 Usage
Description
2-HydroxyMethyl-5-trifluoroMethyl-phenol, a phenolic compound with the molecular formula C8H7F3O2, is characterized by the presence of a hydroxyl group and a trifluoromethyl group. This unique structure endows it with both hydrophilic and lipophilic properties, offering versatile solvent capabilities. It is widely recognized for its antioxidant and antifungal attributes, making it a valuable component in various applications across different industries.
Uses
Used in Pharmaceutical Industry:
2-HydroxyMethyl-5-trifluoroMethyl-phenol is used as an intermediate in the synthesis of various pharmaceuticals due to its versatile chemical properties. Its antioxidant and antifungal properties contribute to the development of medications with enhanced efficacy and safety profiles.
Used in Agrochemical Industry:
In the agrochemical sector, 2-HydroxyMethyl-5-trifluoroMethyl-phenol is utilized as an intermediate for the production of agrochemicals. Its properties make it suitable for the development of pesticides and other agricultural chemicals that can protect crops from diseases and pests.
Used in Personal Care and Cosmetics Industry:
2-HydroxyMethyl-5-trifluoroMethyl-phenol is used as an active ingredient in personal care products and cosmetics for its antioxidant and antifungal properties. It helps in maintaining the quality and extending the shelf life of these products while also providing skin-friendly benefits.
Used in Material Science:
This chemical compound is employed in the research and development of new materials. Its unique properties make it a promising candidate for the creation of innovative materials with improved performance characteristics.
Used in Medical Research:
2-HydroxyMethyl-5-trifluoroMethyl-phenol is utilized in medical research for its potential applications in the development of new therapeutic agents and diagnostic tools. Its antioxidant properties may contribute to the prevention and treatment of various diseases.
It is crucial to handle 2-HydroxyMethyl-5-trifluoroMethyl-phenol with care and adhere to safety protocols to minimize the risk of skin and eye irritation.
Check Digit Verification of cas no
The CAS Registry Mumber 349-66-6 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,4 and 9 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 349-66:
(5*3)+(4*4)+(3*9)+(2*6)+(1*6)=76
76 % 10 = 6
So 349-66-6 is a valid CAS Registry Number.
349-66-6Relevant articles and documents
Optical Control of CRAC Channels Using Photoswitchable Azopyrazoles
Yang, Xingye,Ma, Guolin,Zheng, Sisi,Qin, Xiaojun,Li, Xiang,Du, Lupei,Wang, Youjun,Zhou, Yubin,Li, Minyong
supporting information, p. 9460 - 9470 (2020/06/27)
The Ca2+ release-activated Ca2+ (CRAC) channels control many Ca2+-modulated physiological processes in mammals. Hyperactivating CRAC channels are known to cause several human diseases, including Stormorken syndrome. Here, we show the design of azopyrazole-derived photoswitchable CRAC channel inhibitors (designated piCRACs), which enable optical inhibition of store-operated Ca2+ influx and downstream signaling. Moreover, piCRAC-1 has been applied in vivo to alleviate thrombocytopenia and hemorrhage in a zebrafish model of Stormorken syndrome in a light-dependent manner.
NOVEL SUBSTITUTED PYRIDO-PIPERAZINONE DERIVATIVES AS GAMMA SECRETASE MODULATORS
-
Paragraph 0817-0818, (2018/11/26)
The present invention is concerned with novel substituted pyrido-piperazinone derivatives of Formula (I) wherein R1, R2, R3, R4, R5, L, Z and X have the meaning defined in the claims. The compounds according to the present invention are useful as gamma secretase modulators. The invention further relates to processes for preparing such novel compounds, pharmaceutical compositions comprising said compounds as an active ingredient as well as the use of said compounds as a medicament.
MODULATORS OF DOPAMINE NEUROTRANSMISSION
-
Page/Page column 37, (2009/12/05)
The present invention relates to novel1-(4H-1,3-benzodioxin-2-yl)methanamine derivatives, useful as modulators of dopamine neurotransmission, and more specifically asdopaminergic stabilizers. In other aspects the invention relates to the use of these compounds in a method for therapy and to pharmaceutical compositions comprising the compounds of the invention.
